Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colon and appendiceal…
FDA recommends that Clene leverage additional Neurofilament Light (NfL) data from its three Expanded Access Protocols (EAPs) and the HEALEY…
Prof. Peled, a globally recognized scientific authority who has been involved in multiple successful publicly traded bio-pharma companies, will assist…
Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of…
LNCB74 is a B7-H4-targeting antibody-drug conjugate being developed for multiple cancers in partnership with LigaChem BiosciencesBELTSVILLE, Md., Dec. 10, 2024…
Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT)…
Award is being presented during Advanced Therapies Week 2025 in DallasMarlborough, Massachusetts--(Newsfile Corp. - December 10, 2024) - Phio Pharmaceuticals…
DUBAI, UAE, Dec. 10, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, has solidified…
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Compliancy Group releases exclusion list monitoring and verification tool that automates employee and…
CHICAGO, Dec. 9, 2024 /PRNewswire/ -- The National Association for Healthcare Quality® (NAHQ) proudly announced two prestigious healthcare industry awards…